Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomy
NCT05782270Phase 4Recruiting
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Apr 2023
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of warfarin in coronary artery disease (CAD), sponsored by National Center for Cardiovascular Disease. Started Apr 2023; status: recruiting.
02
Drugs
warfarin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05782270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05782270.